Episode 19: NIVOPOSTOP - nivolumab post op - a GORTEC triump with Yungan Tao episode artwork

EPISODE · May 11, 2026 · 38 MIN

Episode 19: NIVOPOSTOP - nivolumab post op - a GORTEC triump with Yungan Tao

from Deep Margin · host Dr Ben O'Leary and Dr Will Ince

Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.

Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.

NOW PLAYING

Episode 19: NIVOPOSTOP - nivolumab post op - a GORTEC triump with Yungan Tao

0:00 38:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Deep Margin?

This episode is 38 minutes long.

When was this Deep Margin episode published?

This episode was published on May 11, 2026.

What is this episode about?

Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.

Can I download this Deep Margin episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!